128 related articles for article (PubMed ID: 8960022)
1. Cytologic assessment before and after intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis.
Loggie BW; Fleming RA; Geisinger KR
Acta Cytol; 1996; 40(6):1154-8. PubMed ID: 8960022
[TBL] [Abstract][Full Text] [Related]
2. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin.
Loggie BW; Fleming RA; McQuellon RP; Russell GB; Geisinger KR
Am Surg; 2000 Jun; 66(6):561-8. PubMed ID: 10888132
[TBL] [Abstract][Full Text] [Related]
3. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma.
Shen P; Hawksworth J; Lovato J; Loggie BW; Geisinger KR; Fleming RA; Levine EA
Ann Surg Oncol; 2004 Feb; 11(2):178-86. PubMed ID: 14761921
[TBL] [Abstract][Full Text] [Related]
4. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in the treatment of peritoneal carcinomatosis.
Gammon DC; Dutton T; Piperdi B; Zybert J; Wolfe SH; Nguyen E; Sbat D; Pillarisetty VG; Sullivan M; Whalen GF
Am J Health Syst Pharm; 2009 Jul; 66(13):1186-90. PubMed ID: 19535657
[TBL] [Abstract][Full Text] [Related]
5. Thoracic complications in patients undergoing intraperitoneal heated chemotherapy with mitomycin following cytoreductive surgery.
Chen MY; Chiles C; Loggie BW; Choplin RH; Perini MA; Fleming RA
J Surg Oncol; 1997 Sep; 66(1):19-23. PubMed ID: 9290688
[TBL] [Abstract][Full Text] [Related]
6. Hyperthermic intraperitoneal chemotherapy in conjunction with surgery for the treatment of recurrent ovarian carcinoma.
Helm CW; Randall-Whitis L; Martin RS; Metzinger DS; Gordinier ME; Parker LP; Edwards RP
Gynecol Oncol; 2007 Apr; 105(1):90-6. PubMed ID: 17173957
[TBL] [Abstract][Full Text] [Related]
7. Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis.
Shen P; Levine EA; Hall J; Case D; Russell G; Fleming R; McQuellon R; Geisinger KR; Loggie BW
Arch Surg; 2003 Jan; 138(1):26-33. PubMed ID: 12511145
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].
Minicozzi A; Borzellino G; Momo EN; Segattini C; Pitoni F; Steccanella F; De Manzoni G
Ann Ital Chir; 2008; 79(4):231-9. PubMed ID: 19093624
[TBL] [Abstract][Full Text] [Related]
9. Intraperitoneal hyperthermic perfusion chemotherapy of patients with chemotherapy-resistant peritoneal disseminated ovarian cancer.
Hager ED; Dziambor H; Höhmann D; Mühe N; Strama H
Int J Gynecol Cancer; 2001; 11 Suppl 1():57-63. PubMed ID: 11489005
[TBL] [Abstract][Full Text] [Related]
10. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: experience with 501 procedures.
Levine EA; Stewart JH; Russell GB; Geisinger KR; Loggie BL; Shen P
J Am Coll Surg; 2007 May; 204(5):943-53; discussion 953-5. PubMed ID: 17481516
[TBL] [Abstract][Full Text] [Related]
11. Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis.
McQuellon RP; Loggie BW; Fleming RA; Russell GB; Lehman AB; Rambo TD
Eur J Surg Oncol; 2001 Feb; 27(1):65-73. PubMed ID: 11237495
[TBL] [Abstract][Full Text] [Related]
12. Intraperitoneal hyperthermic chemotherapy using carboplatin: a phase I analysis in ovarian carcinoma.
Lentz SS; Miller BE; Kucera GL; Levine EA
Gynecol Oncol; 2007 Jul; 106(1):207-10. PubMed ID: 17498782
[TBL] [Abstract][Full Text] [Related]
13. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis from small bowel adenocarcinoma.
Jacks SP; Hundley JC; Shen P; Russell GB; Levine EA
J Surg Oncol; 2005 Aug; 91(2):112-7; discussion 118-9. PubMed ID: 16028284
[TBL] [Abstract][Full Text] [Related]
14. Appendiceal neoplasms with peritoneal dissemination: outcomes after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy.
Stewart JH; Shen P; Russell GB; Bradley RF; Hundley JC; Loggie BL; Geisinger KR; Levine EA
Ann Surg Oncol; 2006 May; 13(5):624-34. PubMed ID: 16538401
[TBL] [Abstract][Full Text] [Related]
15. Effects of intraperitoneal hyperthermic chemotherapy in ovarian cancer.
Ryu KS; Kim JH; Ko HS; Kim JW; Ahn WS; Park YG; Kim SJ; Lee JM
Gynecol Oncol; 2004 Aug; 94(2):325-32. PubMed ID: 15297169
[TBL] [Abstract][Full Text] [Related]
16. [Intraperitoneal hyperthermic chemotherapy (IPHC), a promising treatment of peritoneal carcinomatosis].
Detroz B; Elias D; Damia E; Debaene B; Rougier P; Lasser P
Bull Cancer; 1994 Mar; 81(3):182-93. PubMed ID: 7894126
[TBL] [Abstract][Full Text] [Related]
17. Treatment of peritoneal carcinomatosis from ovarian cancer by surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
Robella M; Vaira M; Marsanic P; Mellano A; Borsano A; Cinquegrana A; Sottile A; De Simone M
Minerva Chir; 2014 Feb; 69(1):27-35. PubMed ID: 24675244
[TBL] [Abstract][Full Text] [Related]
18. Treatment of ovarian cancer with paclitaxel- or carboplatin-based intraperitoneal hyperthermic chemotherapy during secondary surgery.
Bae JH; Lee JM; Ryu KS; Lee YS; Park YG; Hur SY; Ahn WS; Namkoong SE
Gynecol Oncol; 2007 Jul; 106(1):193-200. PubMed ID: 17466362
[TBL] [Abstract][Full Text] [Related]
19. Cytoreduction and intraperitoneal heated chemotherapy for the treatment of endometrial carcinoma recurrent within the peritoneal cavity.
Helm CW; Toler CR; Martin RS; Gordinier ME; Parker LP; Metzinger DS; Edwards RP
Int J Gynecol Cancer; 2007; 17(1):204-9. PubMed ID: 17291254
[TBL] [Abstract][Full Text] [Related]
20. Long-term survival of peritoneal carcinomatosis of colorectal origin.
Verwaal VJ; van Ruth S; Witkamp A; Boot H; van Slooten G; Zoetmulder FA
Ann Surg Oncol; 2005 Jan; 12(1):65-71. PubMed ID: 15827780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
